# SCI Pharmtech Inc. - Inspection Records

Source: https://www.globalkeysolutions.net/companies/sci-pharmtech-inc/38edf740-19b5-4fbf-bd65-e8cd87a7b1db

> Inspection records and compliance data for SCI Pharmtech Inc. in Taoyuan City, None. Access full analysis and detailed observations.

---

## Details

- Name: SCI Pharmtech Inc.
- FEI Number: 3004065859
- City: Taoyuan City
- State: None
- Country Name: Taiwan
- Address Line 1: Luzhu Dist. 309, No. 61 Ln.; Haihu N. Rd.
- Zip Code: None
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING

## Related Documents

- [483 - SCI Pharmtech Inc. - 2025-06-06](https://www.globalkeysolutions.net/records/483/sci-pharmtech-inc/ad8a9849-6618-43b2-ada7-5addfaf165da) — source: FDA, date: June 6, 2025
- [FDA Inspection 1274464 - SCI Pharmtech Inc. - 2025-06-06](https://www.globalkeysolutions.net/records/fda_inspections/sci-pharmtech-inc/dd9abc18-d7ee-418e-a605-efce30c5189d) — source: FDA, date: June 6, 2025
- [FDA Inspection 1274464 - SCI Pharmtech Inc. - 2025-06-06](https://www.globalkeysolutions.net/records/fda_inspections/sci-pharmtech-inc/299c6338-7efa-4d31-923f-82b823b9a1c2) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 6, 2025
- [FDA Inspection 1106854 - SCI Pharmtech Inc. - 2019-09-05](https://www.globalkeysolutions.net/records/fda_inspections/sci-pharmtech-inc/20071554-aa6c-4c79-87ca-d83681fb3160) — classification: No Action Indicated (NAI), source: FDA, date: September 5, 2019
- [FDA Inspection 1028693 - SCI Pharmtech Inc. - 2017-09-15](https://www.globalkeysolutions.net/records/fda_inspections/sci-pharmtech-inc/fc1f0e1b-6497-4bfd-ada4-531c71e4de0e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 15, 2017
- [FDA Inspection 908076 - SCI Pharmtech Inc. - 2014-12-19](https://www.globalkeysolutions.net/records/fda_inspections/sci-pharmtech-inc/c0c30589-5767-4376-8d3e-9a701cba2430) — classification: No Action Indicated (NAI), source: FDA, date: December 19, 2014
- [FDA Inspection 783663 - SCI Pharmtech Inc. - 2012-04-20](https://www.globalkeysolutions.net/records/fda_inspections/sci-pharmtech-inc/79bd72b4-a9dd-4bd4-8fe4-0ea8b9c66596) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 20, 2012

## Related Companies

- [PolyPeptide Laboratories, Inc.](https://www.globalkeysolutions.net/companies/polypeptide-laboratories-inc/9d05664c-4a42-45cc-81f6-ef85c356ecc1)
- [Sigma-Aldrich Manufacturing LLC](https://www.globalkeysolutions.net/companies/sigma-aldrich-manufacturing-llc/e6637246-5655-4a30-849d-a25e3a5cd06c)
- [MSD International GmbH](https://www.globalkeysolutions.net/companies/msd-international-gmbh/a9448cbd-d3cc-4427-a1d5-22dc511c3c07)
- [Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd.](https://www.globalkeysolutions.net/companies/jiangsu-jiaerke-pharmaceuticals-group-corp-ltd/7ccd91ae-2b6a-43f7-acc5-6c182cec0d11)
- [Signa S.A. de C.V.](https://www.globalkeysolutions.net/companies/signa-sa-de-cv/378a704e-5acb-49b8-9cd6-32503b29b3fc)
- [Almac Sciences Limited](https://www.globalkeysolutions.net/companies/almac-sciences-limited/90ccdc83-facd-4798-aef2-460034d63adf)
- [Partner Therapeutics Inc](https://www.globalkeysolutions.net/companies/partner-therapeutics-inc/837081c1-0ffa-4c06-94c1-4ce65e130882)
- [AmbioPharm, Inc](https://www.globalkeysolutions.net/companies/ambiopharm-inc/6a51f093-2f5b-433d-8e97-8e33820a50bf)
- [Kyongbo Pharmaceutical Co., Ltd.](https://www.globalkeysolutions.net/companies/kyongbo-pharmaceutical-co-ltd/6b8fd90f-4fa3-4c7b-9ed6-a8a8f4b511da)
- [SAFC, Inc.](https://www.globalkeysolutions.net/companies/safc-inc/8b9b439f-c427-4b43-85d2-81ce982736be)

## Related Officers

- [Nicholas J. Presto](https://www.globalkeysolutions.net/people/nicholas-j-presto/2ecdd573-6662-4d07-b93c-ddb9c603bcfa)